WEINSTEIN ROBERT has filed 18 insider transactions across 3 companies since January 2023.
Most recent transaction: a grant/award of 119170 shares of PharmaCyte Biotech, Inc. ($PMCB) on March 31, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | PharmaCyte Biotech, Inc. | $PMCB | WEINSTEIN ROBERT | Director | A | Stock Option (Right to Buy) | 119170 | $0.00 | 119,170.0000 | 10,134,160 | 9999.99% | 1.18% |
| Feb. 27, 2026 | XWELL, Inc. | $XWEL | WEINSTEIN ROBERT | Director | A | Common Stock | 100000 | $0.00 | 215,231.0000 | 5,761,486 | 86.78% | 1.74% |
| April 25, 2025 | PharmaCyte Biotech, Inc. | $PMCB | WEINSTEIN ROBERT | Director | A | Stock Option (Right to Buy) | 63233 | $0.00 | 63,233.0000 | 0 | 9999.99% | 0.00% |
| Dec. 12, 2025 | PharmaCyte Biotech, Inc. | $PMCB | WEINSTEIN ROBERT | Director | A | Common Stock | 75000 | $0.00 | 75,000.0000 | 6,795,779 | 9999.99% | 1.10% |
| Dec. 12, 2025 | PharmaCyte Biotech, Inc. | $PMCB | WEINSTEIN ROBERT | Director | F | Common Stock | 33750 | $1.02 | 41,250.0000 | 6,795,779 | 45.00% | 0.50% |
| Aug. 6, 2025 | TAO Synergies Inc. | $TAOX | WEINSTEIN ROBERT | Chief Financial Officer | A | Employee Stock Option (right to buy) | 7000 | $0.00 | 7,000.0000 | 1,565,200 | 9999.99% | 0.45% |
| Oct. 17, 2025 | TAO Synergies Inc. | $TAOX | WEINSTEIN ROBERT | Chief Financial Officer | A | Common Stock, par value $0.0001 per share | 10000 | $0.00 | 20,574.0000 | 2,549,600 | 94.57% | 0.39% |
| Oct. 17, 2025 | TAO Synergies Inc. | $TAOX | WEINSTEIN ROBERT | Chief Financial Officer | F | Common Stock, par value $0.0001 per share | 4000 | $7.23 | 16,574.0000 | 2,549,600 | 19.44% | 0.16% |
| June 30, 2025 | TAO Synergies Inc. | $TAOX | WEINSTEIN ROBERT | Chief Financial Officer | F | Common Stock, par value $0.0001 per share | 6164 | $7.85 | 10,574.0000 | 1,392,881 | 36.83% | 0.44% |
| June 30, 2025 | TAO Synergies Inc. | $TAOX | WEINSTEIN ROBERT | Chief Financial Officer | A | Common Stock, par value $0.0001 per share | 15410 | $0.00 | 16,738.0000 | 1,392,881 | 1160.39% | 1.11% |
| June 2, 2025 | XWELL, Inc. | $XWEL | WEINSTEIN ROBERT | Director | A | Common Stock, par value $0.01 | 107407 | $0.00 | 115,231.0000 | 5,261,024 | 1372.79% | 2.04% |
| June 2, 2025 | XWELL, Inc. | $XWEL | WEINSTEIN ROBERT | Director | A | Employee stock option (right to buy) | 117886 | $0.00 | 117,886.0000 | 5,261,024 | 9999.99% | 2.24% |
| Nov. 15, 2024 | XWELL, Inc. | $XWEL | WEINSTEIN ROBERT | Director | A | Employee stock option (right to buy) | 30825 | $0.00 | 30,825.0000 | 4,818,681 | 9999.99% | 0.64% |
| April 30, 2024 | PharmaCyte Biotech, Inc. | $PMCB | WEINSTEIN ROBERT | Director | A | Stock Option (Right to Buy) | 38009 | $0.00 | 38,009.0000 | 0 | 9999.99% | 0.00% |
| May 30, 2023 | XWELL, Inc. | $XWEL | WEINSTEIN ROBERT | Director | P | Common Stock | 25000 | $0.25 | 156,485.0000 | 4,167,295 | 19.01% | 0.60% |
| May 26, 2023 | XWELL, Inc. | $XWEL | WEINSTEIN ROBERT | Director | P | Common Stock | 25000 | $0.25 | 131,485.0000 | 4,167,295 | 23.48% | 0.60% |
| Jan. 5, 2023 | XWELL, Inc. | $XWEL | WEINSTEIN ROBERT | Director | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 4,682,767 | 9999.99% | 6.41% |
| Jan. 5, 2023 | XWELL, Inc. | $XWEL | WEINSTEIN ROBERT | Director | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 4,682,767 | 9999.99% | 6.41% |